• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Freudenberg Medical acquires majority stake in Hemoteq AG

Freudenberg Medical acquires majority stake in Hemoteq AG

August 18, 2015 By MassDevice

feudenberg-medical-pr-150818-thumbFreudenberg Medical, a global developer and manufacturer of specialty components and minimally invasive device solutions for the medical device and pharmaceutical industry, has acquired the majority of Hemoteq AG, a provider of surface coating technologies and related services for medical devices.

Hemoteq, based in Würselen, Germany, develops innovative coating solutions for combination products like drug eluting stents, as well as coatings for catheters and cochlear implants. Hemoteq is also the market leader for drug-coated balloon catheters. The company holds over 100 technology patents in surface technologies.

“Hemoteq’s coating technology adds a key technology component to our portfolio and represents an important milestone in our long-term strategy to provide a full suite of innovative technology services to our global medical device OEM customers,” said Jorg Schneewind, president and CEO of Freudenberg Medical.

Hemoteq provides comprehensive services from the development of the medical device to regulatory approval and serial production. Freudenberg Medical develops and manufactures minimally invasive systems as well as components made of silicone, thermoplastics and specialty metals; those surfaces can be modified with active-ingredient coatings for optimal efficacy of the medical device.

“The product and service spectrum of Hemoteq perfectly complements the capabilities of Freudenberg Medical,” said Max Kley, president of Freudenberg Medical Europe and specialty components. “With the combination of our material and processing expertise and Hemoteq’s leading coating technologies, we can provide our customers a unique portfolio of product solutions.”

Under the transaction, Freudenberg Medical will acquire 75% of Hemoteq AG from the current shareholders, Earlybird Venture Capital and Pinova Capital. The remaining shares are held by the founders of Hemoteq, Michael Hoffmann and Roland Horres, who together with the CFO, Thomas Löwen, will continue management of the company. Kley will become chairman of the supervisory board.

“Freudenberg Medical offers Hemoteq excellent market access to offer our solutions worldwide,” said Michael Hoffmann, CEO of Hemoteq AG. “The long-term orientation and financial stability of Freudenberg assures our customers that we can reliably support them over long development processes and throughout their product life cycles.”

Freudenberg Medical
www.FreudenbergMedical.com

Filed Under: News Well Tagged With: Freudenberg Medical

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy